Stem Cell Study Seeks To Wean Non-Related Transplant Recipients From Anti-Rejection Drugs
The immunosuppressive drugs required by organ transplant recipients after surgery can have serious side effects with prolonged use, including infection, heart disease and cancer. In an effort to reduce, or potentially eliminate the need for anti-rejection medications, researchers at Northwestern Memorial Hospital and Northwestern University’s Feinberg School of Medicine are investigating the efficacy of a stem cell transplant after organ transplant.
[Read the full article here]Related News:
Early-Stage Multiple Sclerosis Reversed By Stem Cell Transplant
Patient’s own stem cells used to treat advanced heart disease
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus